We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
851
PUT
Cigna
CI
$76.6B
$22.5M 0.02%
112,600
+84,900
+306% +$18.5M
SRNE
852
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$22.5M 0.02%
2,952,835
+1,142,466
+63% +$9.69M
FULC icon
853
Fulcrum Therapeutics
FULC
$248M
$22.5M 0.02%
+798,101
New +$15.1M
TCOM icon
854
Trip.com Group
TCOM
$27.5B
$22.5M 0.02%
730,948
-1,405,681
-66% -$40.4M
CSCO icon
855
Cisco
CSCO
$450B
$22.5M 0.02%
412,546
-2,488,839
-86% -$140M
MMM icon
856
3M
MMM
$89B
$22.4M 0.02%
152,753
-206,326
-57% -$33.4M
BEPC icon
857
Brookfield Renewable
BEPC
$6.12B
$22.3M 0.02%
575,544
-265,916
-32% -$11.1M
SBNY
858
PUT
DELISTED
Signature Bank
SBNY
$22.1M 0.02%
81,300
+33,100
+69% +$8.31M
NEE.PRP
859
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$22.1M 0.02%
433,338
-319,394
-42% -$16.7M
VET icon
860
Vermilion Energy
VET
$1.73B
$22.1M 0.02%
2,240,034
-540,700
-19% -$3.96M
AVB icon
861
CALL
AvalonBay Communities
AVB
$27.1B
$22.1M 0.02%
99,700
+52,400
+111% +$11.8M
CS
862
DELISTED
Credit Suisse Group
CS
$22.1M 0.02%
2,238,514
-770,524
-26% -$7.87M
TME icon
863
PUT
Tencent Music
TME
$14.5B
$22M 0.02%
3,036,000
+1,364,300
+82% +$13.4M
OXY icon
864
PUT
Occidental Petroleum
OXY
$57B
$21.9M 0.02%
741,300
-150,300
-17% -$4.01M
CRK icon
865
Comstock Resources
CRK
$3.97B
$21.9M 0.02%
2,118,599
-385,156
-15% -$2.61M
AVNS icon
866
Avanos Medical
AVNS
$1.17B
$21.9M 0.02%
702,235
+187,548
+36% +$6.36M
EXPE icon
867
PUT
Expedia Group
EXPE
$31.2B
$21.9M 0.02%
133,600
-80,200
-38% -$12.4M
QVCGA
868
DELISTED
QVC Group Inc Series A
QVCGA
$21.9M 0.02%
42,972
+18,245
+74% +$10.3M
WBD icon
869
CALL
Warner Bros
WBD
$64.6B
$21.9M 0.02%
861,800
+200,900
+30% +$5.65M
CONX
870
DELISTED
CONX Corp. Class A Common Stock
CONX
$21.8M 0.02%
2,228,806
+210,477
+10% +$2.06M
GDOT icon
871
Green Dot
GDOT
$753M
$21.8M 0.02%
432,341
-16,740
-4% -$805K
SSYS icon
872
Stratasys
SSYS
$697M
$21.7M 0.02%
1,009,739
-244,448
-19% -$5.3M
AIRC
873
DELISTED
Apartment Income REIT Corp.
AIRC
$21.7M 0.02%
443,611
-24,704
-5% -$1.25M
ROKU icon
874
CALL
Roku
ROKU
$21.1B
$21.7M 0.02%
69,100
-37,000
-35% -$13.9M
VECO icon
875
Veeco
VECO
$3.15B
$21.6M 0.02%
973,650
-2,788
-0.3% -$62.1K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.